Gene Hartzell

… pressure and it's looking for a bottom to slide to," said Gene McGillian, a broker and analyst with Tradition Energy. The ..... pressure and it's looking for a bottom to slide to," said Gene McGillian, a broker and analyst with Tradition Energy. The …

… of Washington have successfully reconstructed the whole genome sequence of a fetus . This will allow doctors to look at single gene defects, otherwise known as Mendelian disorders, which affect one percent of newborns. These disorders include Huntington's …

… March. Stocks are 27.1% above the five-year average for this time of year, down from a 29.2% premium a week earlier. Gene McGillian, broker and analyst at Tradition Energy, said gas prices aren't likely to continue much higher beyond $2.75 …

… to the disappointment over the Fed's action yesterday that investors felt was not enough to help boost the economy," said Gene McGillian, analyst at Tradition Energy in Stamford, Connecticut. "This market is still looking for a bottom," he added …

… biggest source of Google's mobile revenue, generating roughly 40 percent of the total, according to Piper Jaffray analyst Gene Munster. Mobile search has long been focused on local information, such as finding which local stores have discounts or which …

… didn't hit that level until Aug. 31 last year. "Right now, it still looks like we are going to push above 4-tcf," said Gene McGillian, a broker and analyst at Tradition Energy. On Thursday, broad declines across financial markets, including commodities …

… genome consists of two copies of every gene , one from the father and one from the ..... the 16p11.2 area, they studied each gene at a time and eventually 'silencing' them ..... further demonstrate the importance of the gene region in the development of the brain …

… in London. With so much at stake, the U.S. Trials often rival the Olympics themselves for tension and excitement as the chance to compete for gold is either a reality or taken away. (Reporting by Gene Cherry; Editing by Tom Bartlett)

… trading 7.4% above its 50-day moving average and 11.2% above its 200-day moving average. Genetic Technologies (NASDAQ: GENE ) is trading down on above-normal volume today, seeing a price drop on a volume of 1.1 million, or three times its average …